(Reuters) — Europe’s top court today opened the door to certain stem cell patents in the European Union by ruling that an organism incapable of developing into a human being is not a human embryo and may be patented.
European Patent Office
Europe spikes Edwards Lifesciences’ TAVI patent in war with Medtronic
Medtronic claims a win in European patent row with Edwards Lifesciences
UPDATE: OrbusNeich claims European stent patent win over Boston Scientific
UPDATED Feb. 13, 2012 with comment from Boston Scientific.
OrbusNeich claimed a win over Boston Scientific (NYSE:BSX) in a European patent battle over stent technology.